Coming for the king: Keytruda dominates the immunotherapy market, but challengers are lining up

https://www.statnews.com/2020/09/22/coming-for-the-king-keytruda-dominates-the-immunotherapy-market-but-challengers-are-lining-up/?utm_source=STAT+Newsletters&utm_campaign=0426250959-Cancer_Briefing&utm_medium=email&utm_term=0_8cab1d7961-0426250959-149692869

STAT Plus: Coming for the king: Keytruda dominates the immunotherapy market, but challengers are lining up

By ADAM FEUERSTEIN

ANNE WESTON/FRANCIS CRICK INSTITUTE VIA WELLCOME

At this year's ESMO gathering, drug makers used data presentation to argue their medicines can stand up to Merck's.

READ MORE